1. Academic Validation
  2. Novel N-(aryl/heteroaryl)-2-chlorobenzenesulfonamide derivatives: Synthesis and anticancer activity evaluation

Novel N-(aryl/heteroaryl)-2-chlorobenzenesulfonamide derivatives: Synthesis and anticancer activity evaluation

  • Bioorg Chem. 2020 Nov;104:104309. doi: 10.1016/j.bioorg.2020.104309.
Anita Bułakowska 1 Jarosław Sławiński 2 Kamila Siedlecka-Kroplewska 3 Grzegorz Stasiłojć 4 Marcin Serocki 5 Mateusz Heldt 5
Affiliations

Affiliations

  • 1 Department of Organic Chemistry, Medical University of Gdańsk, Gen. J. Hallera 107, 80-416 Gdańsk, Poland. Electronic address: anita.bulakowska@gumed.edu.pl.
  • 2 Department of Organic Chemistry, Medical University of Gdańsk, Gen. J. Hallera 107, 80-416 Gdańsk, Poland. Electronic address: jaroslaw@gumed.edu.pl.
  • 3 Department of Histology, Medical University of Gdańsk, Dębinki 1, 80-211 Gdańsk, Poland.
  • 4 Department of Cell Biology and Immunology, Intercollegiate Faculty of Biotechnology UG-MUG, Medical University of Gdańsk, Dębinki 1, 80-211 Gdańsk, Poland.
  • 5 Department of Pharmaceutical Technology and Biochemistry, Gdańsk University of Technology, G. Narutowicza 11/12, 80-233 Gdańsk, Poland.
Abstract

A new series of N-(aryl/heteroaryl)-2-chlorobenzenesulfonamide derivatives 4-21 have been synthesized, and evaluated at the National Cancer Institute (USA) for their in vitro activities against a panel of 60 different human Cancer cell lines. Among them, compounds 16, 20 and 21 exhibited remarkable cytotoxic activity against numerous human Cancer cell lines. We found that sulfonamide derivative 21 appeared to be more selective than compounds 16 and 20. In comparison to compounds 16 and 20 it showed higher cytotoxic activity against A549 non-small cell lung adenocarcinoma and HCT-116 colon carcinoma cells and was less toxic to HEK-293 human embryonic kidney cells and HaCaT immortalized human keratinocytes. Treatment of A549 and HCT-116 cells with compound 21 resulted in the G0/G1-cell cycle arrest with a concomitant increase in p53 and p21 protein levels. Moreover, compound 21 led to ATP depletion and disruption of the mitochondrial membrane potential in both studied cell lines. Our results suggest that 2,4-dichloro-N-(quinolin-8-yl and/or 1H-indazol-7-yl)benzenesulfonamides serve as novel promising Anticancer agents.

Keywords

A549 cells; Anticancer activity; Benzenesulfonamides; Cell cycle; Flow cytometry; HCT-116 cells; Synthesis.

Figures
Products